Abstract
In the primary treatment of apparent uterine-confined endometrial carcinoma, pelvic ± para-aortic lymphadenectomy has been considered the standard of care. Although some retrospective data suggest that the sentinel lymph node algorithm without complete lymphadenectomy can be used without jeopardizing oncologic outcome, prospective data are lacking. To assess the 36 month incidence of pelvic/non-vaginal recurrence in women with pathologically confirmed stage I intermediate-risk endometrioid endometrial carcinoma who have bilateral negative pelvic sentinel lymph nodes. We hypothesize that patients with stage I, intermediate-risk endometrioid endometrial carcinoma who have bilateral negative pelvic sentinel lymph nodes will demonstrate a pelvic/non-vaginal recurrence rate comparable to historical estimate of stage I, intermediate-risk endometrioid endometrial carcinoma patients (estimated 2.5%). This prospective multicenter single-arm observational study will follow women with stage I, intermediate risk endometrioid endometrial adenocarcinoma who have undergone successful hysterectomy, bilateral salpingo-oophorectomy, and bilateral sentinel lymph node biopsies, for recurrence. All patients will undergo lymphatic mapping using indo...Continue Reading
References
Apr 16, 1999·Statistics in Medicine·T A GooleyB E Storer
May 3, 2000·Lancet·C L CreutzbergM van Lent
Jun 28, 2000·American Journal of Obstetrics and Gynecology·A MarianiK C Podratz
Feb 19, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ate G J Van der ZeeWim J Sluiter
Nov 27, 2008·Journal of the National Cancer Institute·Pierluigi Benedetti PaniciCostantino Mangioni
Dec 17, 2008·Lancet·UNKNOWN ASTEC study groupM K B Parmar
Mar 9, 2010·Lancet·R A NoutUNKNOWN PORTEC Study Group
Mar 1, 2012·Gynecologic Oncology·Joyce N BarlinNadeem R Abu-Rustum
Jul 4, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Charles F LevenbackCornelia L Trimble
Feb 16, 2013·International Journal of Clinical Oncology·Mariam M AlHilli, Andrea Mariani
Mar 13, 2014·The Journal of Obstetrics and Gynaecology Research·Nadeem R Abu-Rustum
Jan 10, 2016·Gynecologic Oncology·Ane Gerda Zahl ErikssonMario M Leitao
Sep 8, 2016·Journal of the National Cancer Institute·Joanne KotsopoulosUNKNOWN Hereditary Breast Cancer Clinical Study Group
Nov 29, 2016·JAMA Oncology·Jonathan A FrostJo Morrison
Feb 6, 2017·The Lancet Oncology·Emma C RossiJohn F Boggess
Aug 26, 2018·The Lancet Oncology·Michael FrumovitzNadeem R Abu-Rustum
Sep 5, 2018·Gynecologic Oncology·Brooke A SchlappeMario M Leitao
Oct 12, 2018·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·Frédéric AmantCarien L Creutzberg
Jan 15, 2019·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Jvan CasarinGretchen E Glaser
Citations
Feb 2, 2021·Frontiers in Oncology·Yu GuYang Xiang
Dec 29, 2020·Journal of Minimally Invasive Gynecology·Emma C Rossi, Edward Tanner
Mar 28, 2021·Gynecologic Oncology·Dimitrios NasioudisNawar A Latif
May 4, 2021·Frontiers in Behavioral Neuroscience·Alex L DealEvgeny A Budygin
Jul 25, 2021·Journal of Clinical Medicine·Ane Gerda Z ErikssonAnne Cathrine Staff
Aug 7, 2021·Future Oncology·Cem OnalFerah Yildiz